Ra Capital Management, L.P. Olema Pharmaceuticals, Inc. Transaction History

Ra Capital Management, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$2.04 - $4.61 $552,252 - $1.25 Million	-270,712 Reduced 53.66%	233,793 $952,000
Q1 2022 May 16, 2022	SELL	$3.89 - $9.43 $6.4 Million - $15.5 Million	-1,645,899 Reduced 76.54%	504,505 $2.15 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $54.5 $79.8 Million - $117 Million	2,150,404 New	2,150,404 $103 Million

145

58.3M

141K

23.1K

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $248M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.